TAK, US8740602052

Takeda stock: Average target rises to USD 20.74. Target for Takeda stock sits 5.60 percent higher

Published on 10/16/2026 at 17:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Analysts raised the average target to USD 20.74 on October 15, 2026. Takeda stock costs EUR 17.40 on October 16, 2026, with USD 62.1 billion market cap.

Analyst target and reporting date

On October 15, 2026, the average 12-month target moved from USD 20.58 to USD 20.74.
Takeda's market capitalization was USD 62.1 billion on October 16, 2026.
Takeda stock costs EUR 17.40 at 5:38 p.m. CEST at Lang & Schwarz on October 16, 2026.
Takeda's second-quarter results are scheduled for October 29, 2026.

TAK, US8740602052, Illustration mit AI erstellt.

Takeda's average 12-month analyst target rose from USD 20.58 to USD 20.74 on October 15, 2026, according to TradingView. The revised average target was based on estimates from 14 analysts. At Lang & Schwarz, Takeda stock was trading at EUR 17.40 on October 16, 2026 at 5:38 p.m. CEST.

Target distance remains measurable

The USD 20.74 average target stood 5.60 percent above Takeda's USD 19.64 home-market price at 11:46 a.m. EDT on October 16, 2026. The target range ran from USD 16.96 to USD 23.36, giving investors a broad spread around the consensus midpoint. TradingView also reported 10 Buy ratings and 7 Hold ratings among 17 covering analysts on October 15, 2026.

Valuation and October 29 results

Takeda's market capitalization was USD 62.1 billion on October 16, 2026. Its price-to-earnings ratio was 55.47 and its dividend yield was 3.00 percent at the same market snapshot. The valuation figures describe the NYSE-listed American depositary receipt in USD, while the euro quote provides the German investor view.

Takeda said on October 15, 2026, that it will release its second-quarter fiscal year 2026 results on October 29, 2026. The company also scheduled its investor webcast for 7:00 p.m. to 8:15 p.m. JST that day, according to Takeda.

Comparison with peers

Takeda: price-to-earnings ratio 55.47, market capitalization USD 62.1 billion

AbbVie (NYSE, USD): 0.36 percent, price-to-earnings ratio 80.14, market capitalization USD 502.6 billion

Bristol-Myers Squibb (NYSE, USD): 0.30 percent, price-to-earnings ratio 13.39, market capitalization USD 124.1 billion

Euro price after hours

The Lang & Schwarz quote places Takeda at EUR 17.40 in the after-hours phase on October 16, 2026 at 5:38 p.m. CEST. Takeda is listed on the TSE and NYSE, with the home-market quote in JPY and the American depositary receipt in USD. The further course of trading is shown by the continuously updated real-time quote of Takeda stock.